Sees Q1 revenue $280M-$285M, consensus $253.59M
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on LNTH:
- Lantheus Blasts Up as Earnings Impress
- Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
- Lantheus presents data on piflufolastat F 18 at 2023 ASCO symposium
- Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels
- Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time